Modulating interstitial pressure and oncolytic viral delivery and distribution

Details for Australian Patent Application No. 2009253682 (hide)

Owner ONCOLYTICS BIOTECH INC.

Inventors Pandha, Hardev; Thompson, Bradley G.; Coffey, Matthew C.

Agent Griffith Hack

Pub. Number AU-A-2009253682

PCT Pub. Number WO2009/143610

Priority 61/056,276 27.05.08 US; 61/113,845 12.11.08 US

Filing date 27 May 2009

Wipo publication date 3 December 2009

International Classifications

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/436 (2006.01)

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/143610 Priority application(s): WO2009/143610

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009253683-Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

2009253675-Systems and methods for expressionbased discrimination of distinct clinical disease states in prostate cancer